Department of Pharmacology and Experimental Neuroscience, 985880 Nebraska Medical Center, University of Nebraska Medical Center, Omaha, NE 68198, USA.
Department of Pharmacology and Experimental Neuroscience, 985880 Nebraska Medical Center, University of Nebraska Medical Center, Omaha, NE 68198, USA.
Brain Res. 2019 Dec 1;1724:146446. doi: 10.1016/j.brainres.2019.146446. Epub 2019 Sep 12.
In the era of combined antiretroviral therapy (cART), HIV-1 infection has transformed from adeath sentenceto a manageable, chronic disease. Although the lifeexpectancy of HIV+ individuals is comparable to that of the uninfectedsubjects paradoxically, there is increased prevalence ofage-associatedcomorbidities such asatherosclerosis, diabetes, osteoporosis & neurological deficits in the context of HIV infection. Drug abuse is a commoncomorbidityofHIV infection andis often associated withincreased neurological complications. Chronic neuroinflammation (abnormal microglial and astrocyte activation) and neuronal synaptodendritic injury are the features of CNS pathology observed inHIV (+) individualsthat are takingcART & that abuse drugs. Neuroinflammation is thedrivingforceunderlying prematureaging associated with HIV (+) infection, cART and drugs of abuse. Autophagy is a highly conserved process critical for maintaining cellular homeostasis. Dysregulated autophagyhas been shown to be linked with abnormal immune responses & aging. Recent emerging evidence implicatesthe role ofHIV/HIV proteins, cART, & abused drugsin disrupting theautophagy process in brain cells such as microglia, astrocytes, and neurons. It can thus be envisioned that co-exposure of CNS cells to HIV proteins, cART and/or abused drugs couldhavesynergistic effects on theautophagy process, thereby leading to exaggerated microglial/astrocyte activation, ultimately, promotingthe aging process. Restoration of autophagic functioncould thusprovide an alternative therapeuticstrategy formitigating neuroinflammation & ameliorating the premature aging process. The current review aims to unravel the role of dysregulated autophagy in the context of single or co-exposure of microglia, astrocytes, and neurons to HIV/HIV proteins, drugs of abuse &/or cART and will also discuss the pathways involved in dysregulated autophagy-mediated neuroinflammation.
在联合抗逆转录病毒疗法(cART)时代,HIV-1 感染已从死刑转变为可管理的慢性疾病。尽管 HIV+个体的预期寿命与未感染者相当,但 HIV 感染背景下,年龄相关的合并症(如动脉粥样硬化、糖尿病、骨质疏松症和神经缺陷)的患病率却有所增加。药物滥用是 HIV 感染的常见合并症,通常与神经并发症的增加有关。慢性神经炎症(异常小胶质细胞和星形胶质细胞激活)和神经元突触树突损伤是接受 cART 治疗且滥用药物的 HIV(+)个体中枢神经系统病理学的特征。神经炎症是与 HIV(+)感染、cART 和滥用药物相关的过早衰老的驱动因素。自噬是维持细胞内稳态的关键过程。已证明失调的自噬与异常免疫反应和衰老有关。最近的新证据表明,HIV/HIV 蛋白、cART 和滥用药物在破坏小胶质细胞、星形胶质细胞和神经元等脑细胞的自噬过程中发挥作用。因此,可以想象,中枢神经系统细胞同时暴露于 HIV 蛋白、cART 和/或滥用药物可能会对自噬过程产生协同作用,从而导致小胶质细胞/星形胶质细胞过度激活,最终促进衰老过程。因此,恢复自噬功能可能为减轻神经炎症和改善过早衰老过程提供一种替代治疗策略。本综述旨在揭示失调的自噬在单独或同时暴露于 HIV/HIV 蛋白、滥用药物和/或 cART 的小胶质细胞、星形胶质细胞和神经元中的作用,并讨论涉及失调的自噬介导的神经炎症的途径。